AAAAAA

   
Results: 1-13 |
Results: 13
A phase I study of Onyx-015, an ELB-attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer (vol 6, pg 798, 2000)
Authors: Ganly, I Kirn, D Eckhardt, SG Rodriguez, GI Soutar, DS Otto, R Robertson, AG Park, O Gulley, ML Heise, C VonHoff, DD Kaye, SB
Citation: I. Ganly et al., A phase I study of Onyx-015, an ELB-attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer (vol 6, pg 798, 2000), CLIN CANC R, 7(3), 2001, pp. 754-754
The accuracy of head and neck carcinoma sentinel lymph node biopsy in the clinically NO neck
Authors: Shoaib, T Soutar, DS MacDonald, DG Camilleri, IG Dunaway, DJ Gray, HW McCurrach, GM Bessent, RG MacLeod, TIF Robertson, AG
Citation: T. Shoaib et al., The accuracy of head and neck carcinoma sentinel lymph node biopsy in the clinically NO neck, CANCER, 91(11), 2001, pp. 2077-2083
A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intramorally to patients with recurrent head and neck cancer (vol 6, pg 798, 2000)
Authors: Ganly, I Kirn, D Eckhardt, SG Rodriguez, GI Soutar, DS Otto, R Robertson, AG Park, O Gulley, ML Heise, C VonHoff, DD Kaye, SB
Citation: I. Ganly et al., A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intramorally to patients with recurrent head and neck cancer (vol 6, pg 798, 2000), CLIN CANC R, 6(9), 2000, pp. 3797-3797
A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer
Authors: Ganly, I Kirn, D Eckhardt, SG Rodriguez, GI Soutar, DS Otto, R Robertson, AG Park, O Gulley, ML Heise, C Von Hoff, DD Kaye, SB
Citation: I. Ganly et al., A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer, CLIN CANC R, 6(3), 2000, pp. 798-806
Current role of gene therapy in head and neck cancer
Authors: Ganly, I Soutar, DS Kaye, SB
Citation: I. Ganly et al., Current role of gene therapy in head and neck cancer, EUR J SUR O, 26(4), 2000, pp. 338-343
A couple of good ideas from Canniesburn
Authors: Godwin, Y Soutar, DS
Citation: Y. Godwin et Ds. Soutar, A couple of good ideas from Canniesburn, BR J PL SUR, 53(8), 2000, pp. 711-712
Natural history and patterns of recurrence of tongue tumours
Authors: Haddadin, KJ Soutar, DS Webster, MHC Robertson, AG Oliver, RJ MacDonald, DG
Citation: Kj. Haddadin et al., Natural history and patterns of recurrence of tongue tumours, BR J PL SUR, 53(4), 2000, pp. 279-285
Robert James Ratcliffe 1957-2000
Authors: Soutar, DS
Citation: Ds. Soutar, Robert James Ratcliffe 1957-2000, BR J PL SUR, 53(4), 2000, pp. 355-356
p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy
Authors: Ganly, I Soutar, DS Brown, R Kaye, SB
Citation: I. Ganly et al., p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy, BR J CANC, 82(2), 2000, pp. 392-398
A suggested method for sentinel node biopsy in squamous cell carcinoma of the head and neck
Authors: Shoaib, T Soutar, DS Prosser, JE Dunaway, DJ Gray, HW McCurrach, GM Bessent, RG Robertson, AG Oliver, R MacDonald, DG
Citation: T. Shoaib et al., A suggested method for sentinel node biopsy in squamous cell carcinoma of the head and neck, HEAD NECK, 21(8), 1999, pp. 728-733
Improved survival for patients with clinically T1/T2, no tongue tumors undergoing a prophylactic neck dissection
Authors: Haddadin, KJ Soutar, DS Oliver, RJ Webster, MH Robertson, AG MacDonald, DG
Citation: Kj. Haddadin et al., Improved survival for patients with clinically T1/T2, no tongue tumors undergoing a prophylactic neck dissection, HEAD NECK, 21(6), 1999, pp. 517-525
Interstitial iridium-192 implantation for recurrent and/or locally advanced head and neck cancer
Authors: Sandhu, APS Robertson, AG Soutar, DS Webster, MH McNee, SG Deehan, C Paul, J Dunaway, D
Citation: Aps. Sandhu et al., Interstitial iridium-192 implantation for recurrent and/or locally advanced head and neck cancer, CL ONCOL-UK, 11(6), 1999, pp. 371-378
Carcinoma of the tongue: the speech therapist's perspective
Authors: Jackson, MS Wrench, AA Soutar, DS Robertson, AG
Citation: Ms. Jackson et al., Carcinoma of the tongue: the speech therapist's perspective, BR J ORAL M, 37(3), 1999, pp. 200-204
Risultati: 1-13 |